Related Experiment Video
Updated: Jun 22, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
HbA1c variability associated with dementia risk in people with type 2 diabetes
Chris Moran1,2,3,4, Rachel A Whitmer5,6, Zoe Dove6,7
1School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Insights
Glycemic control variability, even with optimal HbA1c levels, increases dementia risk in type 2 diabetes patients. Minimizing blood sugar fluctuations is crucial for brain health.
Area of Science:
- Endocrinology
- Neurology
- Public Health
Background:
- Poor glycemic control is a known risk factor for dementia.
- The impact of glycemic variability on dementia risk, particularly in individuals with well-managed blood sugar, remains unclear.
Purpose of the Study:
- To investigate the association between long-term glycosylated hemoglobin A1c (HbA1c) variability and dementia risk.
- To determine if HbA1c variability increases dementia risk even in individuals with optimal HbA1c levels.
Main Methods:
- A cohort of 171,964 individuals with type 2 diabetes was analyzed.
- Five measures of HbA1c variability, including standard deviation (SD), were used to assess dementia risk.
- Analyses adjusted for demographic factors and comorbidities.
Main Results:
- Increased HbA1c variability, measured by SD, was significantly associated with a higher hazard of dementia (aHR=1.15).
- This association was pronounced in individuals with mean HbA1c levels below 8%, including those with optimal levels (<6% or 6-8%).
- No significant association was found for those with mean HbA1c ≥ 8%.
Conclusions:
- Greater HbA1c variability poses an increased risk for dementia, irrespective of achieving ideal HbA1c targets.
- These findings underscore the clinical importance of managing glycemic variability to mitigate dementia risk.
Introduction:
Although poor glycemic control is associated with dementia, it is unknown if variability in glycemic control, even in those with optimal glycosylated hemoglobin A1c (HbA1c) levels, increases dementia risk.
Methods:
Among 171,964 people with type 2 diabetes, we evaluated the hazard of dementia association with long-term HbA1c variability using five operationalizations, including standard deviation (SD), adjusting for demographics and comorbidities.
Results:
The mean baseline age was 61 years (48% women). Greater HbA1c SD was associated with greater dementia hazard (adjusted hazard ratio = 1.15 [95% confidence interval: 1.12, 1.17]). In stratified analyses, higher HbA1c SD quintiles were associated with greater dementia hazard among those with a mean HbA1c < 6% (P = 0.0004) or 6% to 8% (P < 0.0001) but not among those with mean HbA1c ≥ 8% (P = 0.42).
Discussion:
Greater HbA1c variability is associated with greater dementia risk, even among those with HbA1c concentrations at ideal clinical targets. These findings add to the importance and clinical impact of recommendations to minimize glycemic variability.
Highlights:
We observed a cohort of 171,964 people with type 2 diabetes (mean age 61 years). This cohort was based in Northern California between 1996 and 2018. We examined the association between glycosylated hemoglobin A1c (HbA1c) variability and dementia risk. Greater HbA1c variability was associated with greater dementia hazard. This was most evident among those with normal-low mean HbA1c concentrations.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Psychoneuroimmunology: Diabetes and Cancer